Medicine and Dentistry
Beta Interferon
100%
Electron Therapy
63%
Multiple Sclerosis
54%
Single Nucleotide Polymorphism
45%
Patient
27%
Therapeutic Procedure
27%
Inpatient
18%
Cell Cycle
9%
Protein
9%
Follow up
9%
Interferon
9%
Glutamate Receptor
9%
Disease Marker
9%
Gene
9%
Zinc Finger Protein
9%
GRIA3
9%
AMPA
9%
Guanosine Triphosphatase Activating Protein
9%
Association
9%
Genome Wide Association Study
9%
Neuroscience
Beta Interferon
100%
Single-Nucleotide Polymorphism
45%
Multiple Sclerosis
45%
Cell Cycle
9%
Interferon
9%
Genome-Wide Association Study
9%
Glutamate Receptor
9%
Relapsing Remitting Multiple Sclerosis
9%
Guanosine Triphosphatase Activating Protein
9%
AMPA
9%
GRIA3
9%
Zinc Finger
9%
Protein
9%
Gene
9%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Interferon
100%
Multiple Sclerosis
54%
Protein
9%
Interferon
9%
Disease Marker
9%
Glutamate Receptor
9%
Guanosine Triphosphatase Activating Protein
9%
Zinc Finger Protein
9%
Alpha Amino 3 Hydroxy 5 Methyl 4 Isoxazolepropionic Acid
9%
Biochemistry, Genetics and Molecular Biology
Veterinary Science and Veterinary Medicine